- Novo Nordisk Says It’s Suing Hims to Halt Obesity Drug Copycats Bloomberg.com
- Novo Nordisk sues Hims & Hers over copycat versions of Wegovy drugs; Hims stock plunges 27% CNBC
- Hims & Hers Withdraws Knockoff Weight-Loss Pill After Regulatory Scrutiny The New York Times
- Wegovy maker sues Hims & Hers after company launches $49 weight-loss pill USA Today
- Lawsuit against Hims & Hers should be ‘wake-up call’ for compounders, Novo chief counsel says statnews.com
date:2026-02-09 17:13:00